Stock Track | Shares of WUXI APPTEC Surge on Reported Plans for Asset Sales

Stock Track

Oct 04, 2024

Shares of WUXI APPTEC Co., Ltd (02359.HK) soared 16.21% on Thursday amid reports that the Chinese biotech firm and its related companies are exploring the divestment of certain assets in response to potential U.S. restrictions.

According to a Financial Times report, WUXI APPTEC is considering selling its WUXI Advanced Therapies unit, which manufactures cell and gene therapies and has operations in the United States. The report, citing sources familiar with the matter, also indicated that WUXI Biologics is gauging interest in its European production facilities.

The reported asset sale plans come as the U.S. House of Representatives recently passed a draft of the Biosecure Act, which designates the WUXI companies as "biotechnology companies of concern" due to alleged military ties. If enacted, the legislation could bar U.S. government agencies from using funding or making contracts that involve certain biotechnology equipment or services from designated companies like WUXI.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1140314224"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1140314224\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1140314224?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-10-04 14:32","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1140314224","market":"us","top_or_hot":-1,"title":"Stock Track | Shares of WUXI APPTEC Surge on Reported Plans for Asset Sales","media":"Stock Track","content":"<p>Shares of WUXI APPTEC Co., Ltd (02359.HK) soared 16.21% on Thursday amid reports that the Chinese biotech firm and its related companies are exploring the divestment of certain assets in response to potential U.S. restrictions.</p>\n\n<p>According to a Financial Times report, WUXI APPTEC is considering selling its WUXI Advanced Therapies unit, which manufactures cell and gene therapies and has operations in the United States. The report, citing sources familiar with the matter, also indicated that WUXI Biologics is gauging interest in its European production facilities.</p>\n\n<p>The reported asset sale plans come as the U.S. House of Representatives recently passed a draft of the Biosecure Act, which designates the WUXI companies as \"biotechnology companies of concern\" due to alleged military ties. If enacted, the legislation could bar U.S. government agencies from using funding or making contracts that involve certain biotechnology equipment or services from designated companies like WUXI.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Shares of WUXI APPTEC Surge on Reported Plans for Asset Sales</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Shares of WUXI APPTEC Surge on Reported Plans for Asset Sales\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2024-10-04 14:32</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of WUXI APPTEC Co., Ltd (02359.HK) soared 16.21% on Thursday amid reports that the Chinese biotech firm and its related companies are exploring the divestment of certain assets in response to potential U.S. restrictions.</p>\n\n<p>According to a Financial Times report, WUXI APPTEC is considering selling its WUXI Advanced Therapies unit, which manufactures cell and gene therapies and has operations in the United States. The report, citing sources familiar with the matter, also indicated that WUXI Biologics is gauging interest in its European production facilities.</p>\n\n<p>The reported asset sale plans come as the U.S. House of Representatives recently passed a draft of the Biosecure Act, which designates the WUXI companies as \"biotechnology companies of concern\" due to alleged military ties. If enacted, the legislation could bar U.S. government agencies from using funding or making contracts that involve certain biotechnology equipment or services from designated companies like WUXI.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02359","symbol_name":"药明康德","start_time":0,"source_url":"","article_id":"1140314224","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1140314224","pubTimestamp":1728023559,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of WUXI APPTEC Co., Ltd  soared 16.21% on Thursday amid reports that the Chinese biotech firm and its related companies are exploring the divestment of certain assets in response to potential U.S. restrictions.According to a Financial Times report, WUXI APPTEC is considering selling its WUXI Advanced Therapies unit, which manufactures cell and gene therapies and has operations in the United States. The report, citing sources familiar with the matter, also indicated that WUXI Biologics is ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02359":"药明康德"},"translate_title":"股票跟踪药明康德股价因资产出售计划而飙升","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02359":1},"content_text":"Shares of WUXI APPTEC Co., Ltd (02359.HK) soared 16.21% on Thursday amid reports that the Chinese biotech firm and its related companies are exploring the divestment of certain assets in response to potential U.S. restrictions.\nAccording to a Financial Times report, WUXI APPTEC is considering selling its WUXI Advanced Therapies unit, which manufactures cell and gene therapies and has operations in the United States. The report, citing sources familiar with the matter, also indicated that WUXI Biologics is gauging interest in its European production facilities.\nThe reported asset sale plans come as the U.S. House of Representatives recently passed a draft of the Biosecure Act, which designates the WUXI companies as \"biotechnology companies of concern\" due to alleged military ties. If enacted, the legislation could bar U.S. government agencies from using funding or making contracts that involve certain biotechnology equipment or services from designated companies like WUXI.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}